The Wall Street Journal (online registration required): The U.S. Department of Health and Human Services said Tuesday it awarded a $25 million contract to Mapp Biopharmaceutical Inc. to fund the manufacture of a small amount of experimental Ebola treatment ZMapp and to speed the drug's development.
The new supply to be funded with the 18-month contract would be used in early-stage clinical studies to test the drug's safety and efficacy, HHS said. The contract can be expanded to a value of...
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now